Adicet Bio CAR-T sparks lupus remissions in early trial as ‘new era’ of autoimmune treatment approaches - Fierce Biotech

Adicet Bio CAR-T sparks lupus remissions in early trial as ‘new era’ of autoimmune treatment approaches Fierce Biotech An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus Yahoo Data on a possible lupus treatment are due Monday Stock Titan Wedbush raises Adicet Bio stock price target on lupus trial data Investing.com India Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis daily-tribune.com